Background Stigma is associated with health conditions that drive disease burden in low-
and middle-income countries (LMICs), including HIV, tuberculosis, mental health problems …

Tuberculosis diagnosis and treatment currently revolves around clinical features and
microbiology. The disease however adversely affects patients' psychological, economic, and …

Background Peru is one of the countries with the highest burden of tuberculosis (TB) and
multidrug-resistant tuberculosis (MDR-TB) in the Latin American region and globally. Health …

The COVID-19 pandemic has caused widespread disruptions to tuberculosis (TB) care and
service delivery in 2020, setting back progress in the fight against TB by several years. As …

Background The stigma of tuberculosis (TB) poses a significant challenge to TB control
because it leads to delayed diagnosis and non-adherence. However, few studies on TB …

Background Tuberculosis (TB) affects, and claims the lives of, millions every year. Despite
efforts to find and treat TB, about four million cases were missed globally in 2017. Barriers to …

Background: Stigma, poverty, and lack of knowledge present barriers to the diagnosis and
treatment of chronic infection, especially in resource-limited settings. Chronic Hepatitis B …

Cough assessment is central to the clinical management of respiratory diseases, including
tuberculosis (TB), but strategies to objectively and unobtrusively measure cough are lacking …

The health needs of adolescents and young adults (AYAs) have been neglected in
tuberculosis (TB) care, control, and research. AYAs, who are distinct from younger children …

Directly observed therapy (DOT) for monitoring tuberculosis (TB) treatment is intended to
reduce disease transmission, mortality and acquired drug resistance by facilitating treatment …